These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 15467031)

  • 1. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
    Tao L; Day BW; Hu B; Xiang YB; Wang R; Stern MC; Gago-Dominguez M; Cortessis VK; Conti DV; Van Den Berg D; Pike MC; Gao YT; Yu MC; Yuan JM
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):937-45. PubMed ID: 23539508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
    Leggett CS; Doll MA; States JC; Hein DW
    Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
    Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
    Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
    Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
    Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
    J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender- and smoking-related bladder cancer risk.
    Castelao JE; Yuan JM; Skipper PL; Tannenbaum SR; Gago-Dominguez M; Crowder JS; Ross RK; Yu MC
    J Natl Cancer Inst; 2001 Apr; 93(7):538-45. PubMed ID: 11287448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of biomarkers in epidemiology: the example of bladder cancer.
    Vineis P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
    Poirier MC; Beland FA
    Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
    Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
    Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
    J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylamine exposures and bladder cancer risk.
    Yu MC; Skipper PL; Tannenbaum SR; Chan KK; Ross RK
    Mutat Res; 2002 Sep; 506-507():21-8. PubMed ID: 12351141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
    Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
    J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interindividual variation in carcinogen metabolism and bladder cancer risk.
    Vineis P; Ronco G
    Environ Health Perspect; 1992 Nov; 98():95-9. PubMed ID: 1486869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
    Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
    Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
    Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
    Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.